{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:04:09Z","timestamp":1795043049305,"version":"4.10.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4692,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1046\/j.1523-1755.2003.00776.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:52:23Z","timestamp":1047462743000},"page":"678-685","source":"Crossref","is-referenced-by-count":102,"title":["Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Robert W.","family":"Schrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly K.","family":"McFann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1046\/j.1523-1755.2003.00776.x_bb0010","first-page":"1","article-title":"Bilateral polycystic disease of the kidneys: A follow-up of two hundred and eighty-four patients and their families","volume":"328","author":"Dalgaard","year":"1957","journal-title":"Acta Med Scand"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0020","series-title":"Polycystic Kidney Disease: The Most Common Life-Threatening Genetic Disease","author":"PKD Foundation","year":"2000"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0025","series-title":"USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","author":"US Renal Data System","year":"2001"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0035","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","article-title":"Autosomal dominant polycystic kidney disease in blacks: Clinical course and effects of sickle-cell hemoglobin","volume":"4","author":"Yium","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0040","first-page":"653","article-title":"Pathogenesis of hypertension in autosomal dominant polycystic kidney disease","volume":"11","author":"Chapman","year":"1991","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0045","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJM199010183231602","article-title":"The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease","volume":"323","author":"Chapman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1681\/ASN.V121194","article-title":"Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects","volume":"12","author":"Ecder","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000046231","article-title":"Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease","volume":"21","author":"Ecder","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0060","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal dominant polycystic kidney disease: Results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/ajkd.2000.8970","article-title":"Progress in blood pressure control in autosomal dominant polycystic kidney disease","volume":"36","author":"Ecder","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0070","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"Detection, Evaluation and Treatment of High Blood Pressure Education Program Coordinating Committee: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","author":"The Joint National Committee on Prevention","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1681\/ASN.V81105","article-title":"Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children","volume":"8","author":"Gabow","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/317542a0","article-title":"A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16","volume":"317","author":"Reeders","year":"1985","journal-title":"Nature"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0888-7543(11)80001-7","article-title":"Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23","volume":"18","author":"Kimberling","year":"1993","journal-title":"Genomics"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00041552-200107000-00008","article-title":"Polycystic kidney disease: From the bedside to the gene and back","volume":"10","author":"Grantham","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0272-6386(12)80923-1","article-title":"Hepatic cysts in autosomal dominant polycystic kidney disease","volume":"22","author":"Everson","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0105","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM199209243271303","article-title":"Intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"327","author":"Chapman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-100-5-683","article-title":"Cardiovascular abnormalities associated with adult polycystic kidney disease","volume":"100","author":"Leier","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM198810063191404","article-title":"Echocardiographic findings in autosomal dominant polycystic kidney disease","volume":"319","author":"Hossack","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0120","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","article-title":"Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease","volume":"5","author":"Ivy","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 61","key":"10.1046\/j.1523-1755.2003.00776.x_bb0125","first-page":"S71","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"52","author":"Chapman","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0135","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.V5122048","article-title":"Causes of death in autosomal dominant polycystic kidney disease","volume":"5","author":"Fick","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.1997.385","article-title":"Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells","volume":"52","author":"Chatterjee","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0145","first-page":"F768","article-title":"Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells","volume":"259","author":"Wolf","year":"1990","journal-title":"Am J Physiol"},{"issue":"Suppl","key":"10.1046\/j.1523-1755.2003.00776.x_bb0150","first-page":"S100","article-title":"Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells","volume":"39","author":"Wolf","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0155","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ki.1997.480","article-title":"Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts","volume":"52","author":"Ruiz-Ortega","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0160","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ki.1997.203","article-title":"Angiotensin II and I-arginine in tissue fibrosis: More than blood pressure","volume":"51","author":"Peters","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.1995.407","article-title":"Role of angiotensin II in the expression and regulation of transforming growth factor beta in obstructive nephropathy","volume":"48","author":"Pimentel","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0170","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.1997.03550210043036","article-title":"Trends in antihypertensive drug use in the United States","volume":"278","author":"Siegel","year":"1997","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0175","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0272-6386(96)90158-4","article-title":"Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial","volume":"27","author":"Ihle","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00776.x_bb0185","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","year":"1997","journal-title":"Lancet"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815489227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815489227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T04:41:59Z","timestamp":1622868119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815489227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0085253815489227"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00776.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}